Fibrogen Stock Market Value
| FGEN Stock | USD 1.15 0.02 1.71% |
| Symbol | FibroGen |
FibroGen Price To Book Ratio
Is FibroGen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (2.92) | Revenue Per Share 1.518 | Quarterly Revenue Growth (0.21) | Return On Assets (0.36) |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
FibroGen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to FibroGen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of FibroGen.
| 03/21/2024 |
| 04/20/2024 |
If you would invest 0.00 in FibroGen on March 21, 2024 and sell it all today you would earn a total of 0.00 from holding FibroGen or generate 0.0% return on investment in FibroGen over 30 days. FibroGen is related to or competes with Ardelyx, Zura Bio, Hepion Pharmaceuticals, AVROBIO, Verastem, Mereo BioPharma, and Blueprint Medicines. FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet... More
FibroGen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure FibroGen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess FibroGen upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.93 | |||
| Information Ratio | 0.0988 | |||
| Maximum Drawdown | 113.86 | |||
| Value At Risk | (17.81) | |||
| Potential Upside | 14.71 |
FibroGen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for FibroGen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as FibroGen's standard deviation. In reality, there are many statistical measures that can use FibroGen historical prices to predict the future FibroGen's volatility.| Risk Adjusted Performance | 0.0738 | |||
| Jensen Alpha | 1.04 | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | 0.125 | |||
| Treynor Ratio | 0.2739 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of FibroGen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
FibroGen Backtested Returns
FibroGen is out of control given 3 months investment horizon. FibroGen secures Sharpe Ratio (or Efficiency) of 0.0882, which denotes the company had a 0.0882% return per unit of standard deviation over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.23% are justified by taking the suggested risk. Use FibroGen Semi Deviation of 9.39, downside deviation of 10.93, and Mean Deviation of 8.26 to evaluate company specific risk that cannot be diversified away. FibroGen holds a performance score of 6 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 5.26, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, FibroGen will likely underperform. Use FibroGen potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to analyze future returns on FibroGen.
Auto-correlation | 0.76 |
Good predictability
FibroGen has good predictability. Overlapping area represents the amount of predictability between FibroGen time series from 21st of March 2024 to 5th of April 2024 and 5th of April 2024 to 20th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of FibroGen price movement. The serial correlation of 0.76 indicates that around 76.0% of current FibroGen price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
FibroGen lagged returns against current returns
Autocorrelation, which is FibroGen stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting FibroGen's stock expected returns. We can calculate the autocorrelation of FibroGen returns to help us make a trade decision. For example, suppose you find that FibroGen has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
FibroGen regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If FibroGen stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if FibroGen stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in FibroGen stock over time.
Current vs Lagged Prices |
| Timeline |
FibroGen Lagged Returns
When evaluating FibroGen's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of FibroGen stock have on its future price. FibroGen autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, FibroGen autocorrelation shows the relationship between FibroGen stock current value and its past values and can show if there is a momentum factor associated with investing in FibroGen.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards FibroGen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, FibroGen's short interest history, or implied volatility extrapolated from FibroGen options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out FibroGen Correlation, FibroGen Volatility and FibroGen Alpha and Beta module to complement your research on FibroGen. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for FibroGen Stock analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
FibroGen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.